One thing to note with Eli Lilly and Axiron, is the pending civil court cases around the heart attack risk. They will not want to be seen to be pushing this drug too hard until the case clears post 2017...
in my opinion these claims are baseless (and recent research generally supports)
https://scholar.google.com/scholar?...ne heart failure&hl=en&as_sdt=0,5&as_ylo=2016
But, until the cases clear, Eli Lilly will not want to be seen to be pushing this too hard marketing wise. The FDA is also watching this closely and it will be interesting if they ever comment on the latest research in this space...
- Forums
- ASX - By Stock
- Ann: Acrux presents at BioTrinity-ACR.AX
One thing to note with Eli Lilly and Axiron, is the pending...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 141072 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 73455 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 141072 | 0.061 |
1 | 100000 | 0.060 |
1 | 25184 | 0.059 |
2 | 12100 | 0.058 |
2 | 167543 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 73455 | 1 |
0.070 | 57000 | 2 |
0.072 | 47301 | 1 |
0.073 | 30000 | 3 |
0.075 | 149999 | 1 |
Last trade - 09.59am 10/07/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online